Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy.
about
The extrathyronine actions of iodine as antioxidant, apoptotic, and differentiation factor in various tissuesPPARγ as a Novel Therapeutic Target in Lung CancerBiosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acidDissecting epigenetic silencing complexity in the mouse lung cancer suppressor gene Cadm1Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers.Altered peroxisome-proliferator activated receptors expression in human endometrial cancer.Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailabilityRegulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profileInhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models.PPARα activation can help prevent and treat non-small cell lung cancer.PPAR Agonists for the Prevention and Treatment of Lung Cancer.Possible pathways used to predict different stages of lung adenocarcinoma.Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer.North African Medicinal Plants Traditionally Used in Cancer Therapy.Combination of telmisartan with cisplatin controls oral cancer cachexia in rats.PPARγ antagonist GW9662 induces functional estrogen receptor in mouse mammary organ culture: potential translational significance.A novel mechanism for momordin Ic-induced HepG2 apoptosis: involvement of PI3K- and MAPK-dependent PPARγ activation.Advanced glycation end products induce lipogenesis: regulation by natural xanthone through inhibition of ERK and NF-κB.Microarray expression profiling and bioinformatics analysis of circular RNA expression in lung squamous cell carcinoma.Anti-metastatic effects of isolinderalactone via the inhibition of MMP-2 and up regulation of NM23-H1 expression in human lung cancer A549 cells.Protective effects of pioglitazone on vascular endothelial cell dysfunction induced by high glucose via inhibition of IKKα/β-NFκB signaling mediated by PPARγ in vitro.[PPAR-γ silencing inhibits the apoptosis of A549 cells by upregulating Bcl-2].A novel small inhibitor, LLL12, targets STAT3 in non-small cell lung cancer and
P2860
Q24630154-D086C8CE-5B33-46C3-8B1B-ADECBC86AD75Q28068114-77620CF7-F674-482F-94AF-0535EA02478DQ28252674-2C9A7ADE-5951-4126-AA5A-D12CFF9EEF3EQ28484127-C6AE5498-D1A7-4C0A-B75A-0EED9109C436Q34084838-D4E9B627-9C6A-4659-ADB9-B0A24157332DQ35789097-38C832FB-3C2C-4064-A535-09D593E85363Q35977641-36449F30-364E-458F-86FF-D9301B3DA422Q36162095-78A329DC-5247-470E-A2BD-728DE0C8F457Q36368271-A5068FAE-6070-4707-AE2A-592F323E00C3Q36687528-4CE48F75-3997-4C23-86F1-FC55F01F9E77Q37492629-742A841E-3882-4D80-A639-DC418E10957EQ37517687-A7F2B8B7-5C34-4216-A9EA-83D330E44C11Q37681630-3491555C-F3F0-4952-9797-9ADA003DD092Q38818662-0F69FEFE-6F43-459B-A20E-31A584A4E8B0Q38838622-3B840A68-4FDB-4DA6-8A9C-38E28D06E7ACQ39427056-67481E78-607A-44E0-8C8B-3E876BC33CE6Q42117239-5F04C3FE-893F-448E-9AC4-F49ACCC4D9FDQ44588198-4ED6F3FD-00CE-4F3B-B1C7-C611DE3D236AQ46925565-43219C95-1CCB-4056-8B9A-5E55CDD88B59Q50473781-DED87387-1C54-4255-A293-C0B0CBA0F574Q52595111-854B035A-2C0F-478D-BF3B-B222BD4D005BQ52655126-63DD8ECB-BD72-4325-86B5-3D1212EC32D7Q53120699-E6BE8C0F-736C-4CF5-A844-79F008AF360CQ54442778-A5DACB2C-E342-4D69-9016-0C449A905C99Q58800840-8FE10B25-C6BF-4120-8AF5-CA471B43FFEE
P2860
Molecular cross-regulation between PPAR-γ and other signaling pathways: implications for lung cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular cross-regulation bet ...... tions for lung cancer therapy.
@en
Molecular cross-regulation bet ...... tions for lung cancer therapy.
@nl
type
label
Molecular cross-regulation bet ...... tions for lung cancer therapy.
@en
Molecular cross-regulation bet ...... tions for lung cancer therapy.
@nl
prefLabel
Molecular cross-regulation bet ...... tions for lung cancer therapy.
@en
Molecular cross-regulation bet ...... tions for lung cancer therapy.
@nl
P2093
P2860
P1433
P1476
Molecular cross-regulation bet ...... ations for lung cancer therapy
@en
P2093
Ajaya Kumar Reka
Moloy T Goswami
Rashmi Krishnapuram
Theodore J Standiford
P2860
P304
P356
10.1016/J.LUNGCAN.2011.01.019
P577
2011-02-26T00:00:00Z